Implications of endocrine gland - Derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression

Clinical Cancer Research

Volumn 13, Issue 3, 2007, Pages 868-875

  Ngan, Elly S W ^a,c   Sit, Francesco Y L ^a   Lee, KingLiu ^a   Miao, Xiaoping ^a   Yuan, Zhengwei ^b   Wang, Weilin ^b   Nicholls, John M ^a   Wong, Kenneth K Y ^a   Garcia Barcelo, Mercè ^a   Lui, Vincent C H ^a   Tam, Paul K H ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINA MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROKINETICIN RECEPTOR 1; PROKINETICIN RECEPTOR 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

CELL MOVEMENT; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENDOCRINE GLANDS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 33847394476     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2176     Document Type: Article

References (31)

1. Pearson A, Thierry P, Bodeur GM, Sawada T, Tsuschida Y, Voute PA. Prognosis of low-risk and high-risk neuroblastoma. Neuroblastoma. Amsterdam: Elsevier; 2000. p. 551-60.
2. Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 1995;55:1798-806.
3. Drozynska E, Izycka-Swieszewska E, Niedzwiecki M, Balcerska A, Perek D, Wachowiak J. A correlation of microvascular density and proliferative activity to clinical and histological characteristics in neuroblastoma. Neoplasma 2006;53:247-52.
4. Aoyama M, Asai K, Shishikura T, et al. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 2001;164:51-60.
5. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 1994;14:759-67.
6. Feng X, Jiang H, Baik JC, Edgar C, Eide FF. BDNF dependence in neuroblastoma. J Neurosci Res 2001;64:355-63.
7. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ. Eukaryotic Signal Transduction Group. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron 1993;11:321-31.
8. Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells. Cancer Res 2006;66:4249-55.
9. Kitlinska J, Abe K, Kuo L, et al. Differential effects of neuropeptide Y on the growth and vascularization of neural crest - derived tumors. Cancer Res 2005;65:1719-28.
10. Cheng MY, Bullock CM, Li C, et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002;417:405-10.
11. LeCouter J, Kowalski J, Foster J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001;412:877-84.
12. Kaser A, Winklmayr M, Lepperdinger G, Kreil G. The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep 2003;4:469-73.
13. Soga T, Matsumoto SI, Oda T, et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta-Gene Structure and Expression 2002;1579:173-9.
14. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 2001;59:692-8.
15. Kisliouk T, Levy N, Hurwitz A, Meidan R. Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J Clin Endocrinol Metab 2003;88:3700-7.
16. LeCouter J, Lin R, Tejada M, et al. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci U S A 2003;100:2685-90.
17. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci U S A 2004;101:16813-8.
18. Melchiorri D, Bruno V, Besong G, et al. The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways. Eur J Neurosci 2001;13:1694-702.
19. Mollay C, Wechselberger C, Mignogna G, et al. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol 1999;374:189-96.
20. Boensch M, Oberthuer A, Fischer M, et al. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q. Diagn Mol Pathol 2005;14:177-82.
21. Gotoh T, Hosoi H, Iehara T, et al. Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol 2005;23:5205-10.
22. Nuchtern JG. Perinatal neuroblastoma. Semin Pediatr Surg 2006;15:10-6.
23. Lin R, LeCouter J, Kowalski J, Ferrara N. Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 2002;277:8724-9.
24. Kisliouk T, Podlovni H, Spanel-Borowski K, Ovadia O, Zhou QY, Meidan R. Prokineticins (endocrine gland-derived vascular endothelial growth factor and BV8) in the bovine ovary: expression and role as mitogens and survival factors for corpus luteum-derived endothelial cells. Endocrinology 2005;146:3950-8.
25. Ren Y, Chan HM, Li Z, et al. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 2004;23:4146-54.
26. Goi T, Fujioka M, Satoh Y, et al. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 2004;64:1906-10.
27. Pasquali D, Rossi V, Staibano S, et al. The endocrine gland derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology 2006;147:4245-51.
28. Ng KL, Li JD, Cheng MY, Leslie FM, Lee AG, Zhou QY. Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 2005;308:1923-7.
29. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nature Reviews 2003;3:203-16.
30. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999;17:2264-79.
31. Monje P, Hernandez-Losa J, Lyons RJ, Castellone MD, Gutkind JS. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J Biol Chem 2005;280:35081-4.